Hot Stocks: Brocade Communications Systems, Inc. (NASDAQ:BRCD), Bristol-Myers Squibb Co (NYSE:BMY)

On Friday, Shares of Brocade Communications Systems, Inc. (NASDAQ:BRCD), added 0.20% and closed at $12.28 in the last trading session. The last trading range of the stock ranges between $12.25 and $12.35. The company’s Market capitalization is $4.93 Billion with the total Outstanding Shares of 400.87 million. Brocade Communications Systems, Inc. provides storage area networking (SAN) and Internet protocol (IP) networking solutions for businesses and organizations worldwide. It operates through three segments: SAN Products, IP Networking Products, and Global Services. The SAN Products segment offers infrastructure products and solutions, such as fiber channel SAN backbones, directors, and fabric/embedded switches that assist customers in the development and deployment of storage and server consolidation, and disaster recovery and data security, in addition to to meet compliance requirements regarding data administration; and fabric extension, switching, and routing solutions. The IP Networking Products segment provides Layer 2 and Layer 3 switches and routers that are designed to connect users over private and public networks, counting local area, metro, and within and across data centers. This segment also provides converged network products; a portfolio of related software and hardware-based data networking offerings; and Layer 4-7 platforms, counting ADX and virtual application delivery controller products that are designed for application traffic administration and server load balancing activities. The Global Services segment offers break/fix maintenance, installation, consulting, network administration and software maintenance, and customer support services. The company also provides virtual evolved packet software that mainly addresses mobile applications and services. Brocade Communications Systems, Inc. serves various enterprises and service providers, such as telecommunication firms, cable operators, and mobile carriers.

Technical Analysis: During the 52-week trading session the minimum price at which share price traded, registered at $7.40 and reached to max level of $12.42. The EPS of company is strolling at 0.56.

Shares of Bristol-Myers Squibb Co (NYSE:BMY), dropped -0.51% and closed at $56.37 in the last trading session. The last trading range of the stock ranges between $55.88 and $56.73. The company’s Market capitalization is $93.73 Billion with the total Outstanding Shares of 1.67 billion. Bristol-Myers Squibb Company (BMY) declared recently additional results from the Phase 1/2 open-label CheckMate-032 trial investigating two combination plans of Opdivo (nivolumab) plus Yervoy (ipilimumab) in patients with locally advanced or metastatic urothelial carcinoma (mUC) formerly treated with platinum-based therapy. In these preliminary data, the primary endpoint of investigator-assessed confirmed objective response rate (ORR) was 38.5% (95% CI: 20.2 – 59.4) in patients who received Opdivo 1 mg/kg plus Yervoy 3 mg/kg (n=26) contrast to 26.0% (95% CI: 17.9 – 35.5) in patients treated with Opdivo 3 mg/kg plus Yervoy 1 mg/kg (n=104). No new safety signals have been identified. The incidence of Grade 3-4 treatment-related adverse events (AEs) was 30.8% in the Opdivo 1 mg/kg plus Yervoy 3 mg/kg group and 31.7% in the Opdivo 3 mg/kg plus Yervoy 1 mg/kg group. Treatment-related AEs led to discontinuation of therapy in 7.7% of patients in the Opdivo 1 mg/kg plus Yervoy 3 mg/kg group and 13.5% in the Opdivo 3 mg/kg plus Yervoy 1 mg/kg group.

Technical Analysis: During the 52-week trading session the minimum price at which share price traded, registered at $49.03 and reached to max level of $77.12. The EPS of company is strolling at 2.01.

Leave a Reply

Your email address will not be published. Required fields are marked *